These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9112625)

  • 1. Immunomodulatory activity of a potent thymopentin analog: disulphide bridged beta-mercaptopropionyl-arginyl-lysyl-aspartyl-valyl-tyrosyl-cysteine amide.
    Wieczorek Z; Zimecki M; Trojnar J; Siemion IZ
    Pol J Pharmacol; 1996; 48(1):31-8. PubMed ID: 9112625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulating peptides II. In vitro effects of TP5 analogs on E-rosette formation and cell division.
    Denes L; Szende B; Ember J; Major J; Szporny L; Hajos G; Nyeki O; Schon I; Lapis K; Kisfaludy L
    Immunopharmacol Immunotoxicol; 1987; 9(1):1-18. PubMed ID: 3330094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilized analogs of thymopentin. 2. 1,2- and 3,4-ketomethylene pseudopeptides.
    DeGraw JI; Almquist RG; Hiebert CK; Judd AK; Dousman L; Smith RL; Waud WR; Uchida I
    J Med Chem; 1997 Jul; 40(15):2398-406. PubMed ID: 9240354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further investigations on thymopentin-like fragments of HLA-DQ and their analogs.
    Szewczuk Z; Wieczorek Z; Stefanowicz P; Wilczyński A; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):335-41. PubMed ID: 9523010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory activity of conformationally restricted peptides related to TGF-beta-2 90-99 sequence.
    Wieczorek Z; Słoń JJ; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):209-14. PubMed ID: 9017160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymopentin (TP5), an immunomodulatory peptide, suppresses proliferation and induces differentiation in HL-60 cells.
    Fan YZ; Chang H; Yu Y; Liu J; Zhao L; Yang DJ; Wang R
    Biochim Biophys Acta; 2006 Oct; 1763(10):1059-66. PubMed ID: 16952408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunosuppressive mini-domain of human lactoferrin.
    Siemion IZ; Sloń J; Wieczorek Z
    J Pept Sci; 1995; 1(5):295-302. PubMed ID: 9223008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of TP-5 and its analogs on skin grafts in mice.
    Szende B; Kisfaludy L; Lapis K; Dénes L; Szporny L; Nyéke O; Schön I; Hajós G; Ember J; Constantin M
    J Immunopharmacol; 1985; 7(1):67-78. PubMed ID: 3891868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory activity of disulphide bridged peptides related to lactoferrin immunosuppressive mini-domain.
    Wieczorek Z; Słoń J; Siemion IZ
    Pol J Pharmacol; 1995; 47(5):451-5. PubMed ID: 8868139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 decreases the level of thymocytes forming rosettes with autologous erythrocytes: a new method of determination of interleukin-1 activity.
    Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):371-9. PubMed ID: 3502240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory activity of G-actin fragments containing a thymopentin-like sequence.
    Siemion IZ; Strug I; Wysłouch-Cieszyńska A; Nowak E; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):419-25. PubMed ID: 9437497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilized analogs of thymopentin. 1. 4,5-Ketomethylene pseudopeptides.
    DeGraw JI; Almquist RG; Hiebert CK; Colwell WT; Crase J; Hayano T; Judd AK; Dousman L; Smith RL; Waud WR; Uchida I
    J Med Chem; 1997 Jul; 40(15):2386-97. PubMed ID: 9240353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunomodulatory effects of thymopentin under acute and chronic inflammations in mice].
    Lunin SM; Novoselova TV; Khrenov MO; Glushkova OV; Parfeniuk SB; Smolikhina TI; Fesenko EE; Novoselova EG
    Biofizika; 2009; 54(2):260-6. PubMed ID: 19402538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endogenous immunoregulatory peptides (myelopeptides): structure, function, and mechanism of action].
    Petrov RV; Mikhaĭlova AA; Fonina LA
    Bioorg Khim; 1999 Nov; 25(11):811-5. PubMed ID: 10645485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-inducing activity of a proline-rich polypeptide complex (PRP) from ovine colostrum and its active nonapeptide fragment analogs.
    Zabłocka A; Janusz M; Rybka K; Wirkus-Romanowska I; Kupryszewski G; Lisowski J
    Eur Cytokine Netw; 2001; 12(3):462-7. PubMed ID: 11566627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation of spleen cells in culture stimulated by 7-thia-8-oxoguanosine: evidence that both B- and T-cells are the targets of its action.
    Colic M; Vucevic D; Vasilijic S; Popovic L; Pejanovic V; Jandric D; Medic-Mijacevic L; Rakic L
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):583-90. PubMed ID: 10669901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Lys-residue deletion on the immunomodulatory activity of peptides related to immunosuppressive region of lactoferrin.
    Słoń JI; Siemion IZ; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):211-6. PubMed ID: 8744698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory activity of polysaccharides isolated from Strongylocentrotus nudus eggs.
    Liu C; Xi T; Lin Q; Xing Y; Ye L; Luo X; Wang F
    Int Immunopharmacol; 2008 Dec; 8(13-14):1835-41. PubMed ID: 18834960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat.
    Fernández-Martínez E; Morales-Ríos MS; Pérez-Alvarez V; Muriel P
    Biochem Pharmacol; 2004 Oct; 68(7):1321-9. PubMed ID: 15345321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologically active analogs of thymopentin with enhanced enzymatic stability.
    Heavner GA; Kroon DJ; Audhya T; Goldstein G
    Peptides; 1986; 7(6):1015-9. PubMed ID: 3031628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.